These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. Lanza E; Schatzkin A; Ballard-Barbash R; Corle D; Clifford C; Paskett E; Hayes D; Bote E; Caan B; Shike M; Weissfeld J; Slattery M; Mateski D; Daston C Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):385-92. PubMed ID: 9162305 [TBL] [Abstract][Full Text] [Related]
5. Results from two repeated 5 day dietary records with a 1 y interval among patients with colorectal polyps. Almendingen K; Trygg K; Hofstad B; Veierød MB; Vatn MH Eur J Clin Nutr; 2001 May; 55(5):374-9. PubMed ID: 11378811 [TBL] [Abstract][Full Text] [Related]
7. [Intermediate endpoints in clinical research]. Peters SA; Groenwold RH; Bots ML Ned Tijdschr Geneeskd; 2013; 157(43):A6400. PubMed ID: 24152361 [TBL] [Abstract][Full Text] [Related]
8. Nutrition and colonic polyps: are we what we eat? Morse JH Am J Gastroenterol; 1993 Dec; 88(12):2123-4. PubMed ID: 8249991 [No Abstract] [Full Text] [Related]
9. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. McKeown-Eyssen G; Holloway C; Jazmaji V; Bright-See E; Dion P; Bruce WR Cancer Res; 1988 Aug; 48(16):4701-5. PubMed ID: 3293777 [TBL] [Abstract][Full Text] [Related]
10. Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial. Steck-Scott S; Forman MR; Sowell A; Borkowf CB; Albert PS; Slattery M; Brewer B; Caan B; Paskett E; Iber F; Kikendall W; Marshall J; Shike M; Weissfeld J; Snyder K; Schatzkin A; Lanza E Int J Cancer; 2004 Nov; 112(2):295-305. PubMed ID: 15352043 [TBL] [Abstract][Full Text] [Related]
12. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization. Lanza E; Yu B; Murphy G; Albert PS; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery M; Burt R; Iber F; Shike M; Kikendall JW; Brewer BK; Schatzkin A; Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1745-52. PubMed ID: 17855692 [TBL] [Abstract][Full Text] [Related]
13. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Beresford SA; Johnson KC; Ritenbaugh C; Lasser NL; Snetselaar LG; Black HR; Anderson GL; Assaf AR; Bassford T; Bowen D; Brunner RL; Brzyski RG; Caan B; Chlebowski RT; Gass M; Harrigan RC; Hays J; Heber D; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Jackson RD; Kotchen JM; Kuller LH; LaCroix AZ; Lane DS; Langer RD; Lewis CE; Manson JE; Margolis KL; Mossavar-Rahmani Y; Ockene JK; Parker LM; Perri MG; Phillips L; Prentice RL; Robbins J; Rossouw JE; Sarto GE; Stefanick ML; Van Horn L; Vitolins MZ; Wactawski-Wende J; Wallace RB; Whitlock E JAMA; 2006 Feb; 295(6):643-54. PubMed ID: 16467233 [TBL] [Abstract][Full Text] [Related]
14. The effect of a low-fat, high fiber, fruit and vegetable intervention on rectal mucosal proliferation. Pfeiffer R; McShane L; Wargovich M; Burt R; Kikendall W; Lawson M; Lanza E; Schatzkin A Cancer; 2003 Sep; 98(6):1161-8. PubMed ID: 12973839 [TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial. Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL Trials; 2016 Aug; 17():400. PubMed ID: 27519183 [TBL] [Abstract][Full Text] [Related]
16. Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective. Prentice RL Stat Med; 1990; 9(1-2):161-70; discussion 170-2. PubMed ID: 2345832 [TBL] [Abstract][Full Text] [Related]
17. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Stang A; Seufferlein T Gastrointest Endosc; 2010 Sep; 72(3):671-2. PubMed ID: 20801298 [No Abstract] [Full Text] [Related]
18. Designing phase II studies in cancer with time-to-event endpoints. Owzar K; Jung SH Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409 [TBL] [Abstract][Full Text] [Related]
19. An epidemiologic perspective on biomarkers. Schatzkin A; Freedman L; Schiffman M J Intern Med; 1993 Jan; 233(1):75-9. PubMed ID: 8429292 [TBL] [Abstract][Full Text] [Related]